Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A prospective Single-center Study of Pharmacokinetics and Pharmacogenetics of Regorafenib in Patients with Metastatic Colorectal Cancer

ABSTRACT: Primary endpoint was to evaluate the association between SNPs of UGT1A9 and hand foot syndrome Grade 3.

DISEASE(S): Metastatic Colorectal Cancer

PROVIDER: 2647847 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

The development of new preventive measures and therapeutic methods in the management of hand-foot syndrome by multi-kinase inhibitors regorafenib

Project description:Interventions: 12 weeks /Application of aluminium chloride ointment once a day and application of wound dressing after the presentation of grade 1 hand-foot syndrome Primary outcome(s): Incidence of Grade 3 HFS Study Design: Single arm Non-randomized

| 2647838 | ecrin-mdr-crc

Usefulness of remote monitor system for adverse events in outpatient receiving cancer chemotherapy for colorectal cancer

Project description:Primary outcome(s): The incidence of Grade >=2 hand-foot syndrome (Relapse-Free survival(RFS))

| 104238 | ecrin-mdr-crc

The development of new preventive measures and therapeutic methods in the management of hand-foot syndrome by regorafenib

Project description:Interventions: Effectiveness of prevention of hand-foot syndrome associated with Regorafenib by using aluminum chloride and wound dressing Primary outcome(s): Incidence of Grade 3 HFS Study Design: single arm study, open(masking not used), historical control, single assignment, prevention purpose

| 2613973 | ecrin-mdr-crc

Randomized Controlled Study of Preventive Effect of TDX105 on Regorafenib Induced Dermatologic Toxicities

Project description:Interventions: Experimental group:Fufang Danxiong Granules (TDX105);Control group:Placebo Primary outcome(s): Incidence of grade 3 hand and foot skin reaction Study Design: Cross-sectional

| 37419 | ecrin-mdr-crc

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer

Project description:RATIONALE: Pyridoxine (vitamin B6) may prevent or lessen hand-foot syndrome caused by chemotherapy. It is not yet known whether pyridoxine is more effective than a placebo in preventing hand-foot syndrome. PURPOSE: This phase III randomized trial is studying pyridoxine to see how well it works compared to a placebo in preventing hand-foot syndrome in patients who are receiving capecitabine for advanced colorectal cancer or breast cancer.

| 2046490 | ecrin-mdr-crc

MicroRNA of exosome in Hand, foot and mouth disease serum samples

Project description:The some biomarkers can be found by pairwise comparison. They can distinguish between extremely severe Hand,foot and mouth disease and mild Hand,foot and mouth disease,moreover,they can applied to diagnose extremely severe Hand,foot and mouth disease mild Hand,foot and mouth disease vs.control; extremely severe Hand,foot and mouth disease vs.control; extremely severe Hand,foot and mouth disease vs.mild Hand,foot and mouth disease,verification by qRT-PCR

2013-11-27 | E-GEOD-52780 | biostudies-arrayexpress

Efficacy of hydrocolloid dressing for prophylactic use of hand-foot skin reaction induced by multi targeted kinase inhibitors: a phase III self-controlled study

Project description:Interventions: In addition to the standard care of moisturizing, attach a hydrocolloid dressing for 1 month from the start of multi-kinase inhibitor therapy. the standard care of moisturizing Primary outcome(s): Proportion of grade 2 or higher hand-foot syndrome (only sole) Study Design: Parallel Randomized

| 2649927 | ecrin-mdr-crc